Cover Page The handle http://hdl.handle.net/1887/29414 holds various files of this Leiden University dissertation Author: Sahota, Tarjinder Title: Pharmacology based toxicity assessment : towards quantitative risk prediction in humans Issue Date: 2014-10-30 Pharmacology based toxicity assessment: Towards quantitative risk prediction in humans Tarjinder Sahota PhD. Thesis, Leiden University, October 2014 2 Pharmacology based toxicity assessment: Towards quantitative risk prediction in humans Proefschrift ter verkrijging van de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus Prof. mr. C.J.J.M. Stolker, volgens besluit van het College voor Promoties te verdedigen op donderdag 30 oktober 2014 klokke 11.15 uur door Tarjinder Sahota geboren te Letchworth, United Kingdom in 1982 Promotor Prof. dr. M. Danhof Co-promotor Prof. dr. O.E. Della Pasqua Referent Prof. G. Tucker (Sheffield University, Verenigd Koninkrijk) Overige Leden Prof. dr. P.H. van der Graaf Prof. dr. K. Burggraaf Prof. dr. B. vd Water Prof. dr. T Hankemeier Dr. J.W. van der Laan 2 3 The research leading to this thesis has received funding from GlaxoSmithKline (Worldwide Product Development scholarship) and was performed at the Division of Pharmacology of the Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands. The printing of this thesis was financially supported by: Leiden Academic Centre for Drug Research GlaxoSmithKline Cover and layout by Roweena Asgalari Printed by GVO printers & designers B.V., Ede, The Netherlands ISBN: 978-90-6464-821-2 ©2014 Tarjinder Sahota ([email protected]) No part of this thesis may be reproduced or transmitted in any form or by any means without written permission of the author 4 CONTENTS Section 1 General Introduction 7 Chapter 1 Challenges in the assessment and prediction of safety pharmacology and drug toxicity in humans 9 Chapter 2 Scope and intent of investigation 55 Section 2 Conceptual framework 69 Chapter 3 The impact of composite AUC estimates on the prediction of systemic exposure in toxicology experiments 71 Chapter 4 Application of optimal design concepts to experimental protocols for the evaluation of toxicokinetics and safety thresholds 120 Chapter 5 Use of biomarkers for the characterisation of long-term safety: advantages of a model-based approach for the analysis of toxicology experiments 148 Chapter 6 Utility of model based approaches to predict the risk of adverse events from preclinical toxicology protocols. 178 Section 3 Case study and practical application 211 Chapter 7 Model-based analysis of thromboxane B2 and prostaglandin E2 as biomarkers in the safety evaluation of naproxen. 213 Chapter 8 Model-based prediction of the acute and long-term safety profile of naproxen in rats 249 Section 4 Conclusions and Perspectives 280 Chapter 9 Pharmacology based toxicity assessment: Towards quantitative risk prediction in humans 282 Chapter 10 Nederlandse Samenvatting (Synopsis in Dutch) 320 Acknowledgements 338 Curriculum Vitae 339 List of publications 340 5 6
© Copyright 2024 ExpyDoc